Structural MRI in Huntington's disease and recommendations for its potential use in clinical trials

► Structural MRI has the potential to assess progression in clinical trials. ► The most promising biomarkers in HD are striatal and white matter atrophy. ► Consideration of image acquisition, processing and statistical design is essential. ► Appropriate reporting of study design is vital to allow evaluation of the literature.